Primary Biliary Cholangitis (PBC) is a chronic liver condition affecting thousands of patients across the United States. While new treatments offer hope, the tragic reality is that drugs like Ocaliva have brought severe risks and led many patients to seek legal recourse. Below, AWKO Law details PBC treatment goals, the devastating impact of drug-induced harm, industry duties, patient safety, and why anyone impacted by Ocaliva should contact a specialist pharmaceutical litigation attorney.
PBC Treatment Goals
Managing PBC is a life-long journey. Modern medicine gives patients powerful tools to control the disease, slow progression of liver damage, and maintain overall health.
- The main goals of PBC treatment are to alleviate symptoms, prevent end-stage liver disease, decrease the likelihood of needing a liver transplant, and reduce the risk of mortality.
- First-line therapy typically involves ursodeoxycholic acid (UDCA), which can reduce progression to cirrhosis and delay complications for many patients.
- For those who don’t respond adequately to or tolerate UDCA, medications like Ocaliva (obeticholic acid) are prescribed as a second-line agent. Clinical trials show Ocaliva can improve certain liver function markers, such as alkaline phosphatase, and may reduce inflammation and injury.
- Treatment success rates vary. Real-world data shows only 30-50% of PBC patients have strong biochemical responses to Ocaliva; many continue to struggle with ongoing liver dysfunction and symptoms.
When Treatment Causes Harm
Despite medical advances and good intentions, serious harm can occur—even from the very drugs meant to help.
- Ocaliva was hailed as a breakthrough for PBC but soon came under scrutiny as cases emerged of hepatic decompensation, acute liver failure, and death, sometimes even in patients without advanced cirrhosis.
- The tragic irony: drugs intended to reverse or slow liver disease instead accelerated injury, led to additional health crises, hospitalizations, or need for liver transplant, and ultimately devastated lives.
- Reports document that patients taking Ocaliva, including those correctly dosed, suffered severe itching, fatigue, abdominal pain, jaundice, and liver failure—sometimes fatal or requiring urgent transplant.
- Adverse events led the FDA to issue black box safety warnings. As more than 6,600 adverse event reports mounted and post-marketing clinical trials showed higher death and transplant risks for Ocaliva users, regulatory pressure forced Intercept Pharmaceuticals to withdraw the drug from the U.S. market in 2025.
Focus on Patient Safety: The Manufacturer’s Duty
Pharmaceutical companies must go beyond innovation—they are legally and ethically obliged to protect patient safety.
- Drug manufacturers like Intercept Pharmaceuticals have a duty to rigorously test products, monitor safety, issue clear warnings, and update protocols for vulnerable populations such as those with PBC.
- Allegations against Ocaliva’s manufacturer include failure to warn about the risk and frequency of serious liver injury, insufficient post-market surveillance, downplaying risks in FDA submissions and marketing, and misleading both doctors and patients.
- Lawsuits argue that Intercept should have communicated the dangers sooner and pushed for stricter safety measures, especially in high-risk groups. Not doing so may constitute negligence, failure to warn, or even fraudulent misrepresentation.
- These legal standards matter: a black box warning issued years after launch is powerful evidence in a drug-injury lawsuit. If the warning came too late for your injury, or wasn’t properly conveyed by your healthcare team, you may have grounds for significant compensation.
You Are Not Alone
Ocaliva is not an isolated event—patient stories and class action lawsuits reveal a widespread problem.
- Thousands of PBC patients have come forward, reporting injury, hospitalization, and financial hardship after taking Ocaliva for their chronic liver disease.
- Support networks and advocacy groups have amplified awareness, helping injured patients document their experience, find legal resources, and connect with others in similar situations.
- Class actions and multidistrict litigation are being formed to represent the collective voice of over 10,000 U.S. patients exposed to Ocaliva. Plaintiffs allege the company ignored repeated safety signals, delayed meaningful warnings, and prioritized profits above patient safety.
- In peer-reviewed studies, as many as 7 of 81 Ocaliva patients required liver transplants, and dozens suffered acute liver injury or died—whereas the rates were dramatically lower in comparable placebo groups.
Get a Specialist Lawyer: Why Pharmaceutical Litigation Is Unique
If you believe Ocaliva harmed you or a loved one, do not simply call an accident or general injury lawyer—pharmaceutical litigation demands specialized skill and experience.
- Litigation against drug manufacturers involves complex medical evidence, advanced product liability law, and challenging expert testimony.
- Pharmaceutical companies often retain fleets of specialized defense experts to dispute causation and limit liability. Success hinges on having legal counsel who understands FDA regulations, medicine, and the science of drug risk.
- The best attorneys will meticulously gather pharmacy records, dosing instructions, post-marketing reports, and peer-reviewed studies. They coordinate with medical experts to prove Ocaliva’s direct link to your injury, rather than simply progression of PBC.
- Law firms focused on pharmaceutical litigation—like AWKO Law or similar national teams—combine compassion for patient suffering with fierce advocacy, ensuring that clients are not outmatched. They pursue not only individual claims but collective actions that force drugmakers to improve safety standards for everyone.
Overcoming Industry Resistance and Proving Your Case
Pharmaceutical litigation is a battle—it’s essential to understand:
- You’ll need evidence proving Ocaliva was prescribed, dosing timelines, and documentation of medical complications.
- Medical professionals must support your case, testifying how the drug, not merely underlying illness, contributed to liver injury.
- Your lawyer will build a legal argument that the manufacturer failed to warn, misrepresented or concealed risk data, and neglected its safety responsibilities.
- Successful cases have led to major settlements, with damages potentially including medical bills, lost wages, future disability, pain and suffering, and punitive awards for egregiously unsafe conduct.
What Compensation Could Mean for You
Victims of Ocaliva-caused liver injury may recover:
- Payment for hospital stays, specialist treatment, diagnostics, medications, physical rehabilitation, and transplant surgery.
- Compensation for lost income, reduced earning capacity, and future work limitations.
- Awards for pain, suffering, emotional distress, loss of companionship, and life impact.
- Reimbursement for funeral expenses and costs in cases where patients died as a result of the drug.
- Punitive damages, where courts find reckless or unethical corporate behavior.
The Statute of Limitations: Act Quickly
Legal rights in drug lawsuits are time-sensitive. Statutes of limitations restrict your ability to file—and waiting too long may permanently bar your claim.
- In most states, you have one to three years from the date of injury (or discovery that Ocaliva was likely the cause) to file a lawsuit.
- Time is of the essence: Evidence is lost, memories fade, and missing deadlines leaves patients unprotected. The earlier you speak with a specialist, the stronger your case.
Take The Next Step: Get a Free, Confidential Evaluation
If you are living with PBC and have suffered injury after Ocaliva—or lost someone you love—AWKO Law wants to help. Our team of pharmaceutical litigation specialists will listen, analyze your medical history, and determine whether the manufacturer failed to properly protect you. Consultations are free and confidential, with no upfront fees. Our attorneys excel in drug litigation, and our commitment is holding companies accountable so that patients aren’t harmed in the pursuit of hope.
You Are Not Alone—Contact AWKO Law Today
Join the thousands of others who are stepping forward. Every voice matters; every case brings us closer to safer care for all chronic disease patients.
- Contact AWKO Law for your free case review.
- We fight for justice, compensation, and the safety every PBC patient deserves.